<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmedpharm</journal-id><journal-title-group><journal-title xml:lang="ru">Фармация и фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacy &amp; Pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2307-9266</issn><issn pub-type="epub">2413-2241</issn><publisher><publisher-name>Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical Univer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.19163/2307-9266-2021-9-5-367-376</article-id><article-id custom-type="elpub" pub-id-type="custom">pmedpharm-937</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАЦЕВТИЧЕСКАЯ И ТОКСИКОЛОГИЧЕСКАЯ ХИМИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACEUTICAL AND TOXICOLOGICAL CHEMISTRY</subject></subj-group></article-categories><title-group><article-title>СИНТЕЗ И АНТИОКСИДАНТНАЯ АКТИВНОСТЬ  ПРОИЗВОДНЫХ (E)-3-(3-(4-ОКСО-4H-ХРОМЕН-3-ИЛ) АКРИЛОИЛ)-2H-ХРОМЕН-2-ОНА</article-title><trans-title-group xml:lang="en"><trans-title>SYNTHESIS AND ANTIOXIDANT ACTIVITY  OF (E)-3-(3-(4-OXO-4H-CHROMEN-3-YL)ACRYLOYL) 2H-CHROMEN-2-ONE DERIVATIVES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7891-8338</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шатохин</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shatokhin</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры органической химии</p></bio><bio xml:lang="en"><p>post-graduate student of the Department of Organic Chemistry </p></bio><email xlink:type="simple">shatohin.stanislav95@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7182-462X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тускаев</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tuskaev</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат фармацевтических наук, ведущий научный сотрудник химического факультета, ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»; ведущий научный сотрудник ИНЭОС РАН</p></bio><bio xml:lang="en"><p>Candidate of Sciences (Pharmacy), Leading Researcher, Faculty of Chemistry, Lomonosov Moscow State University; Leading Researcher, Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences</p></bio><email xlink:type="simple">tuskaev@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4654-9974</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гагиева</surname><given-names>С. Ч.</given-names></name><name name-style="western" xml:lang="en"><surname>Gagieva</surname><given-names>S. Ch.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат химических наук, ведущий научный сотрудник химического факультета</p></bio><bio xml:lang="en"><p>Candidate of Sciences (Chemistry), Leading Researcher,</p></bio><email xlink:type="simple">sgagieva@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0889-7855</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поздняков</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pozdnyakov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат фармацевтических наук, доцент кафедры фармакологии с курсом клинической фармакологии</p></bio><bio xml:lang="en"><p>Candidate of Sciences (Pharmacy), Associate Professor of the Department of Pharmacology with a course in Clinical Pharmacology </p></bio><email xlink:type="simple">pozdniackow.dmitry@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2756-9382</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Оганесян</surname><given-names>Э. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Oganesyan</surname><given-names>E. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор фармацевтических наук, профессор, заведующий кафедрой органической химии</p></bio><bio xml:lang="en"><p>Doctor of Sciences (Pharmacy), Professor, Head of the Department of Organic Chemistry </p></bio><email xlink:type="simple">edwardov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Пятигорский медико-фармацевтический институт – филиал федерального государственного &#13;
бюджетного образовательного учреждения высшего образования «Волгоградский государственный &#13;
медицинский университет» Министерства здравоохранения Российской Федерации &#13;
357532, Россия, г. Пятигорск, пр-кт Калинина, 11</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University, &#13;
11, Kalinin Ave., Pyatigorsk, Russia, 357532</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>1. Федеральное государственное бюджетное образовательное учреждение высшего образования&#13;
«Московский государственный университет имени М.В. Ломоносова» &#13;
119991, Россия, г. Москва, Ленинские горы, 1, стр. 3&#13;
2. Федеральное государственное бюджетное учреждение науки «Институт элементоорганических&#13;
соединений имени А.Н. Несмеянова» Российской академии наук (ИНЭОС РАН) &#13;
119991, Россия, г. Москва, ул. Вавилова, 28</institution><country>Россия</country></aff><aff xml:lang="en"><institution>1. Lomonosov Moscow State University, &#13;
Bldg. 3, 1, Leninskie Gory, Moscow, Russia, 119991&#13;
2. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, &#13;
28, Vavilov St., Moscow, Russia, 119991</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования&#13;
«Московский государственный университет имени М.В. Ломоносова» &#13;
119991, Россия, г. Москва, Ленинские горы, 1, стр. 3</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lomonosov Moscow State University, &#13;
Bldg. 3, 1, Leninskie Gory, Moscow, Russia, 119991</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2021</year></pub-date><volume>9</volume><issue>5</issue><fpage>367</fpage><lpage>376</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шатохин С.С., Тускаев В.А., Гагиева С.Ч., Поздняков Д.И., Оганесян Э.Т., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Шатохин С.С., Тускаев В.А., Гагиева С.Ч., Поздняков Д.И., Оганесян Э.Т.</copyright-holder><copyright-holder xml:lang="en">Shatokhin S.S., Tuskaev V.A., Gagieva S.C., Pozdnyakov D.I., Oganesyan E.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmpharm.ru/jour/article/view/937">https://www.pharmpharm.ru/jour/article/view/937</self-uri><abstract><sec><title>Цель</title><p>Цель. На основе результатов прогноза in silico получить и охарактеризовать ряд производных (E)-3-(3-(4-оксо-4H-хромен-3-ил)акрилоил)-2H-хромен-2-она, а также изучить их антиоксидантную активность.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Синтез целевых соединений осуществляли конденсацией замещенных 3-формилхромонов и 3-ацетилкумаринов в условиях кислотного катализа. ЯМР1Н спектры регистрировали на приборе Bruker Avance-400 (400 МГц) и Bruker Avance-300 (300 МГц) в растворах в дейтерированном хлороформе (CDCl3) или дейтерированном диметилсульфоксиде (DMSO-d6). Масс-спектры (ESI) были получены на масс-спектрометре Finnigan LCQ Advantage (США). Температуры плавления соединений определяли на приборе ПТП (М). Квантово-химические расчеты проводили на основе теории функционала плотности с помощью программы Gaussian 09 методом B3LYP/6-311G (d,p), а также с помощью онлайн-сервиса Way2Drug PASS Online. Антирадикальная активность соединений изучена методом DPPH-теста, а хелатирующие свойства оценены о-фенантролиновым методом.</p></sec><sec><title>Результаты</title><p>Результаты. Получено и охарактеризовано 15 производных (E)-3-(3-(4-оксо-4H-хромен-3-ил)акрилоил)-2H-хромен-2-она. Расчеты на основе теории функционала плотности показали, что высшая занятая молекулярная орбиталь, проявляющая электронодонорные свойства, локализована на пропеноновом фрагменте, что подтверждает вероятность проявления антирадикальных свойств. По данным прогноза вероятного спектра биологической активности, полученные соединения с большей вероятностью могут проявлять прямую антиоксидантную активность. По результатам проведенного in vitro изучения антиоксидантной активности установлено, что соединения 1-15 проявляют наибольшую активность в отношение DPPH-радикала, что подтверждает полученные прогностические данные.</p></sec><sec><title>Заключение</title><p>Заключение. Таким образом, на основании данных in silico прогноза получено и охарактеризовано 15 производных (E)-3-(3-(4-оксо-4H-хромен-3-ил)акрилоил)-2H-хромен-2-она, для которых методом in vitro изучена антиоксидантная активность. Установлено, что соединения 1-15 в значительной степени проявляют антирадикальную активность.</p></sec></abstract><trans-abstract xml:lang="en"><p>The aim is based on the results of the in silico prediction, to obtain and characterize a number of (E)-3-(3-(4-oxo-4H-chromen-3-yl)acryloyl)-2H-chromen-2-one derivatives, and also to study their antioxidant activity.</p><sec><title>Materials and methods</title><p>Materials and methods. The synthesis of the target compounds was carried out by condensation of substituted 3-formylchromones and 3-acetylcoumarins under the acid catalysis conditions. 1H NMR spectra were recorded on the instruments of Bruker Avance-400 (400 MHz) and Bruker Avance-300 (300 MHz) in the solutions of CDCl3 or DMSO-d6. Mass spectra (ESI) were obtained on a Finnigan LCQ Advantage mass spectrometer (USA). The melting points of the compounds were determined on a PTP (M) instrument. Quantum-chemical calculations were carried out on the basis of a density functional theory using the Gaussian 09 program using the B3LYP/6-311G (d, p) method, as well as using the Way2Drug (PASS Online) online service. The antiradical activity of the compounds was studied by the DPPH test, and the chelating properties were assessed by the o-phenanthroline method.</p></sec><sec><title>Results</title><p>Results. 15 derivatives of (E)-3-(3-(4-oxo-4H-chromen-3-yl)acryloyl)-2H-chromen-2-one have been obtained and characterized. The calculations based on the density functional theory showed that the highest occupied molecular orbital exhibiting electron-donating properties is localized on the propenone fragment, which confirms the likelihood of the manifestation of antiradical properties. According to the prediction of the probable spectrum of the biological activity, the obtained compounds are more likely to exhibit their direct antioxidant activity. According to the results of the in vitro study of the antioxidant activity, it was found out that compounds 1-15 are the most active in relation to the DPPH radical, which confirms the obtained prognostic data.</p></sec><sec><title>Conclusion</title><p>Conclusion. Thus, based on the in silico prediction data, 15 derivatives of (E)-3-(3-(4-oxo-4H-chromen-3-yl)acryloyl)-2H-chromen-2-one have been obtained and characterized, for which the method antioxidant activity has been studied in vitro. It was found out that compounds 1-15 exhibit the antiradical activity to a large extent.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>3-формилхромон</kwd><kwd>3-ацетилкумарин</kwd><kwd>халконы</kwd><kwd>DFT расчеты</kwd><kwd>антиоксидантная активность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>3-formylchromone</kwd><kwd>3-acetylcoumarin</kwd><kwd>chalcones</kwd><kwd>DFT calculations</kwd><kwd>antioxidant activity</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данное исследование не имело финансовой поддержки от сторонних организаций</funding-statement><funding-statement xml:lang="en">This study did not have any funding from third-party organizations.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Чугунова Е.А., Газизов А.С., Бурилов А.Р., Юсупова Л.М., Пудовик М.А., Синяшин О.Г. Бензофуроксаны: синтез, свойства и биологическая активность // Известия Академии Наук: Серия химическая. – 2019. – Т. 11. – С. 887–910.</mixed-citation><mixed-citation xml:lang="en">Chugunova EA, Gazizov AS, Burilov AR, Yusupova LM, Pudovik MA, Sinyashin OG, Benzofuroxans: synthesis, properties and biological activity [Benzofuroksany: sintez, svojstva i biologicheskaya aktivnost’]. Bulletin of the Academy Sciences: Chemical series. 2019;11:887–910. Russian</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Olennikov D.N., Kashchenko N.I., Chirikova N.K. A Novel HPLC-Assisted Method for Investigation of the Fe2+-Chelating Activity of Flavonoids and Plant Extracts // Molecules. – 2014. – Vol. 19, No.11. – P. 18296–18316. DOI: 10.3390/molecules191118296.</mixed-citation><mixed-citation xml:lang="en">Olennikov DN, Kashchenko NI, Chirikova NK. A Novel HPLC-Assisted Method for Investigation of the Fe2+-Chelating Activity of Flavonoids and Plant Extracts. Molecules. 2014;19(11):18296–316. DOI: 10.3390/molecules191118296.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Waris G., Ahsan H. Reactive oxygen species: Role in the development of cancer and various chronic conditions // J. Carcinog. – 2006. – Vol. 5. – P. 14–21. DOI: 10.1186/1477-3163-5-14.</mixed-citation><mixed-citation xml:lang="en">Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006 May 11;5:14. DOI: 10.1186/1477-3163-5-14.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease // Int. J Biochem. Cell. Biol. – 2007. – Vol. 39, No.1. – P. 44–84. DOI: 10.1016/j.biocel.2006.07.001.</mixed-citation><mixed-citation xml:lang="en">Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84. DOI: 10.1016/j.biocel.2006.07.001.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmad A., Kaleem M., Ahmed Z., Shafiq H. Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-A review // Food Research International. – 2015. – Vol. 77. – P. 221–235. DOI: /10.1016/j.foodres.2015.06.021.</mixed-citation><mixed-citation xml:lang="en">Ahmad A, Kaleem M, Ahmed Z, Shafiq H. Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-A review. Food Research International. 2015;77:221–35. DOI: /10.1016/j.foodres.2015.06.021.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">de Araújo F.F., de Paulo Farias D., Neri-Numa I.A., Pastore G.M. Polyphenols and their applications: An approach in food chemistry and innovation potential // Food Chemistry. – 2021. – Vol. 338. – 127535. DOI: 10.1016/j.foodchem.2020.127535.</mixed-citation><mixed-citation xml:lang="en">de Araújo FF, de Paulo Farias D, Neri-Numa IA, Pastore GM. Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 2021 Feb 15;338:127535. DOI: 10.1016/j.foodchem.2020.127535.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Шатохин С.С., Тускаев В.А., Гагиева С.Ч., Оганесян Э.Т. Синтез гетероциклических аналогов изофлавона и гомоизофлавона на основе 3-формилхромона // Известия Академии Наук: Серия химическая. – 2021. – Т. 6. – С. 1011–1045.</mixed-citation><mixed-citation xml:lang="en">Shatokhin SS, Tuskaev VA, Gagieva SCh, Oganesyan ET. Synthesis of heterocyclic analogs of isoflavone and homoisoflavone based on 3-formylchromone [Sintez geterociklicheskih analogov izoflavona i gomoizoflavona na osnove 3-formilhromona]. Bulletin of the Academy Sciences: Chemical series. 2021;6:1011–45. Russian</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lichota A., Gwozdzinski L., Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency // Eur J Med Chem. – 2019. – Vol. 176. – P. 68–91. DOI: 10.1016/j.ejmech.2019.04.075.</mixed-citation><mixed-citation xml:lang="en">Lichota A, Gwozdzinski L, Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. Eur J Med Chem. 2019 Aug 15;176:68–91. DOI: 10.1016/j.ejmech.2019.04.075.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Loh Y. C., Chan S.Y., Tew W.Y., Oo C.W., Yam M.F. New flavonoid-based compound synthesis strategy for antihypertensive drug development // Life Sciences. – 2020. – Vol. 249. – Art. No. 117512. DOI: 10.1016/j.lfs.2020.117512.</mixed-citation><mixed-citation xml:lang="en">Loh YC, Chan SY, Tew WY, Oo CW, Yam MF. New flavonoid-based compound synthesis strategy for antihypertensive drug development. Life Sci. 2020 May 15;249:117512. DOI: 10.1016/j.lfs.2020.117512.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Perez-Vizcaino F., Fraga C. G. Research trends in flavonoids and health // Archives of Biochemistry and Biophysics. – 2018. – Vol. 646. – P. 107–112. DOI: 10.1016/j.abb.2018.03.022.</mixed-citation><mixed-citation xml:lang="en">Perez-Vizcaino F, Fraga CG. Research trends in flavonoids and health. Arch Biochem Biophys. 2018 May 15;646:107–12. DOI: 10.1016/j.abb.2018.03.022.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Raffa D., Maggio B., Raimondi M.V., Plescia F., Dainone G. Recent discoveries of anticancer flavonoids // European Journal of Medicinal Chemistry. – 2017. – Vol. 142. – P. 213–228. DOI: 10.1016/j.ejmech.2017.07.034.</mixed-citation><mixed-citation xml:lang="en">Raffa D, Maggio B, Raimondi MV, Plescia F, Daidone G. Recent discoveries of anticancer flavonoids. Eur J Med Chem. 2017 Dec 15;142:213–228. DOI: 10.1016/j.ejmech.2017.07.034.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships // Journal of Nutritional Biochemistry. – 2002. – Vol. 13, No.10. – P. 572–584. DOI: 10.1016/S0955-2863(02)00208-5.</mixed-citation><mixed-citation xml:lang="en">Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 2002 Oct;13(10):572–584. DOI: 10.1016/s0955-2863(02)00208-5.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mladěnka P., Zatloukalová L., Filipský T., Radomír Hrdina. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity // Free Radical Biology &amp; Medicine. – 2010. – Vol. 49, No.6. – P. 963–975. DOI: 10.1016/j.freeradbiomed.2010.06.010.</mixed-citation><mixed-citation xml:lang="en">Mladenka P, Zatloukalová L, Filipský T, Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med. 2010 Sep 15;49(6):963–75. DOI: 10.1016/j.freeradbiomed.2010.06.010.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Procházková D., Boušová I., Wilhelmová N. Antioxidant and prooxidant properties of flavonoids // Fitoterapia. – 2011. – Vol. 82. – P. 513–523. DOI: 10.1016/j.fitote.2011.01.018.</mixed-citation><mixed-citation xml:lang="en">Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011 Jun;82(4):513–23. DOI: 10.1016/j.fitote.2011.01.018.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Agati G., Azzarello E., Pollastri S., Tattini M. Flavonoids as antioxidants in plants: Location and functional significance // Plant Science. – 2012. – Vol. 196. – P. 67–76. DOI: 10.1016/j.plantsci.2012.07.014.</mixed-citation><mixed-citation xml:lang="en">Agati G, Azzarello E, Pollastri S, Tattini M. Flavonoids as antioxidants in plants: location and functional significance. Plant Sci. 2012 Nov;196:67–76. DOI: 10.1016/j.plantsci.2012.07.014.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Самет А.В., Сильянова Е.А., Ушкарев В.И., Семенова М.Н., Семенов В.В. Синтез 3,4-диарил- и 3-арил-4-ацилпирролов и изучение их антимитотической активности // Известия Академии Наук: Серия химическая. – 2018. – Т. 5. – С. 858–865.</mixed-citation><mixed-citation xml:lang="en">Samet AV, Silyanova EA, Ushkarev VI, Semenova MN, Semenov VV. Synthesis of 3,4-diaryl- and 3-aryl-4-acylpyrroles and study of their antimitotic activity [Sintez 3,4-diaril- i 3-aril-4-acilpirrolov i izuchenie ih antimitoticheskoj aktivnosti]. Bulletin of the Academy Sciences: Chemical series. 2018;5:858–65. Russian</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Осипова В.П., Половинкина М.А., Телекова Л.Р., Великородов А.В., Степкина Н.Н., Берберова Н.Т. Синтез и антиоксидантная активность новых гидроксипроизводных халконов // Известия Академии Наук: Серия химическая. – 2020. – Т. 5. – С. 504–509.</mixed-citation><mixed-citation xml:lang="en">Osipova VP, Polovinkina MA, Telekova LR, Velikorodov AV, Stepkina NN, Berberova NT. Synthesis and antioxidant activity of new hydroxy derivatives of chalcones [Sintez i antioksidantnaya aktivnost’ novyh gidroksiproizvodnyh halkonov]. Bulletin of the Academy Sciences: Chemical series. 2020; 5: 504-9. Russian</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Foti M.C. Use and Abuse of the DPPH• Radical // J. Agricult. Food Chem. – 2015. – Vol. 63, No.40. – P. 8765–8776.59. DOI: 10.1021/acs.jafc.5b03839.</mixed-citation><mixed-citation xml:lang="en">Foti MC. Use and Abuse of the DPPH(•) Radical. J Agric Food Chem. 2015 Oct 14;63(40):8765–76. DOI: 10.1021/acs.jafc.5b03839.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Benzie I.F., Choi S.W. Antioxidants in food: Content, Measurement, Significance, Action, Cautions, Caveats, and Research Needs // Adv. Food Nutr. Res. – 2014. – Vol. 71. – P. 1–53. DOI: 10.1016/B978-0-12-800270-4.00001-8.</mixed-citation><mixed-citation xml:lang="en">Benzie IF, Choi SW. Antioxidants in food: content, measurement, significance, action, cautions, caveats, and research needs. Adv Food Nutr Res. 2014;71:1–53. DOI: 10.1016/B978-0-12-800270-4.00001-8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Soren S. Antioxidant Potential and Toxicity Study of the Cerium Oxide Nanoparticles Synthesized by Microwave-Mediated Synthesis // Appl. Biochem. Biotechnol. – 2015. – Vol. 177, No.1. – P. 148–161. DOI: 10.1007/s12010-015-1734-8.</mixed-citation><mixed-citation xml:lang="en">Soren S, Jena SR, Samanta L, Parhi P. Antioxidant Potential and Toxicity Study of the Cerium Oxide Nanoparticles Synthesized by Microwave-Mediated Synthesis. Appl Biochem Biotechnol. 2015 Sep;177(1):148–61. DOI: 10.1007/s12010-015-1734-8.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mansour E., Nassar E.M., El-Farargy A.F., Abdelrazek F.M. An Eco-Friendly Synthesis of Some Novel Chromene-Based Heterocyclic Compounds of Biological Interest // Russ. J. Bioorg. Chem. – 2020. – Vol. 46, No.4. – P. 582–589.</mixed-citation><mixed-citation xml:lang="en">Mansour E, Nassar EM, El-Farargy AF, Abdelrazek FM. An Eco-Friendly Synthesis of Some Novel Chromene-Based Heterocyclic Compounds of Biological Interest. Russ J Bioorg Chem. 2020; 46(4):582–9.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mourad A.K., Mohamed F.K., Essawy A.E.-N. I., Sayed S.M. A comprehensive synthesis and antimicrobial evaluation of some fused heterocycles based on coumarin moiety // Arkivoc. – 2018. – No.7. – P. 407–422. DOI: 10.24820/ark.5550190.p010.674.</mixed-citation><mixed-citation xml:lang="en">Mourad AK, Mohamed FK, Essawy AE-NI, Sayed SM. A comprehensive synthesis and antimicrobial evaluation of some fused heterocycles based on coumarin moiety. Arkivoc. 2018;7:407–22. DOI: 10.24820/ark.5550190.p010.674</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Siddiqui Z.N. A convenient synthesis of coumarinyl chalcones using HClO4–SiO2: A green approach // Arab. J. Chem. – 2019. – Vol. 12, No.8. – P. 2788–2797. DOI: 10.1016/J.ARABJC.2015.06.013.</mixed-citation><mixed-citation xml:lang="en">Siddiqui ZN. A convenient synthesis of coumarinyl chalcones using HClO4–SiO2: A green approach. Arab J Chem. 2019;12(8):2788–97. DOI: 10.1016/J.ARABJC.2015.06.013.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Siddiqui Z.N., Musthafa T.N.M. An efficient and novel synthesis of chromonyl chalcones using recyclable Zn(l-proline)2 catalyst in water // Tetrahedron Lett. – 2011. – Vol. 52, No.31. – P. 4008–4013. DOI: 10.1016/j.tetlet.2011.05.118.</mixed-citation><mixed-citation xml:lang="en">Siddiqui ZN, Musthafa TNM. An efficient and novel synthesis of chromonyl chalcones using recyclable Zn(l-proline)2 catalyst in water. Tetrahedron Lett. 2011;52(31):4008–13. DOI: 10.1016/j.tetlet.2011.05.118.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">De Vleeschouwer F., Van Speybroeck V., Waroquier M., Geerlings P., De Proft F. Electrophilicity and nucleophilicity index for radicals // Org. Lett. – 2007. – Vol. 9, No.14. – P. 2720–2724. DOI: 10.1021/ol071038k.</mixed-citation><mixed-citation xml:lang="en">De Vleeschouwer F, Van Speybroeck V, Waroquier M, Geerlings P, De Proft F. Electrophilicity and nucleophilicity index for radicals. Org Lett. 2007 Jul 5;9(14):2721–4. DOI: 10.1021/ol071038k.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Becke A.D. Density-functional exchange-energy approximation with correct asymptotic behavior // Phys. Rev. A. – 1988. – Vol. 38, No.6. – P. 3098–3100. DOI: 10.1103/PhysRevA.38.3098.</mixed-citation><mixed-citation xml:lang="en">Becke AD. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098–100. DOI: 10.1103/physreva.38.3098.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Филимонов Д.А., Дружиловский Д.С., Лагунин А.А., Глориозова Т.А., Рудик А.В., Дмитриев А.В., Погодин П.В., Поройков В.В. Компьютерное прогнозирование спектров биологической активности химических соединений: возможности и ограничения // Biomedical Chemistry: Research and Methods. – 2018. – Т. 1, №1. – e00004. DOI: 10.18097/bmcrm00004.</mixed-citation><mixed-citation xml:lang="en">Filimonov DA, Druzhilovskiy DS, Lagunin AA, Gloriozova TA, Rudik AV, Dmitriev AV, Pogodin PV, Poroikov VV. Computer prediction of biological activity spectra of chemical compounds: possibilities and limitations. Biomedical Chemistry: Research and Methods. 2018; 1(1): e00004. DOI: 10.18097 / bmcrm00004.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Sies H. Oxidative stress: a concept in redox biology and medicine // Redox Biol. – 2015. – Vol. 4. – P. 180–183. DOI: 10.1016/j.redox.2015.01.002.</mixed-citation><mixed-citation xml:lang="en">Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180–3. DOI: 10.1016/j.redox.2015.01.002.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Forrester S.J., Kikuchi D.S., Hernandes M.S., Xu Q., Griendling K.K. Reactive Oxygen Species in Metabolic and Inflammatory Signaling // Circ Res. – 2018. – Vol. 122, No.6. – P. 877–902. DOI: 10.1161/CIRCRESAHA.117.311401.</mixed-citation><mixed-citation xml:lang="en">Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive Oxygen Species in Metabolic and Inflammatory Signaling. Circ Res. 2018 Mar 16;122(6):877–902. DOI: 10.1161/CIRCRESAHA.117.311401.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Shehri S.S. Reactive oxygen and nitrogen species and innate immune response // Biochimie. – 2021. – Vol. 181. – P. 52–64. DOI: 10.1016/j.biochi.2020.11.022.</mixed-citation><mixed-citation xml:lang="en">Al-Shehri SS. Reactive oxygen and nitrogen species and innate immune response. Biochimie. 2021 Feb;181:52–64. DOI: 10.1016/j.biochi.2020.11.022.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Alkadi H. A Review on Free Radicals and Antioxidants. Infect Disord Drug Targets. 2020. – Vol. 20, No.1. – P. 16–26. DOI: 10.2174/1871526518666180628124323.</mixed-citation><mixed-citation xml:lang="en">Alkadi H. A Review on Free Radicals and Antioxidants. Infect Disord Drug Targets. 2020;20(1):16–26. DOI: 10.2174/1871526518666180628124323.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">González M., Tereschuk M.L., Criado S. The activity of propolis in the scavenging of vitamin B2-photogenerated ROS // Redox Rep. – 2015. – Vol. 20, No.6. – P. 246–253. DOI: 10.1179/1351000215Y.0000000033.</mixed-citation><mixed-citation xml:lang="en">González M, Tereschuk ML, Criado S, Reynoso E, Challier C, Agüero MB, Luna L, Ferrrari G, Montaña MP, García NA. The activity of propolis in the scavenging of vitamin B2-photogenerated ROS. Redox Rep. 2015;20(6):246–53. DOI: 10.1179/1351000215Y.0000000033.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Mai W., Xu Y., Xu J. Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis // Front Pharmacol. – 2020. – Vol. 11. – P. 185. DOI: 10.3389/fphar.2020.00185.</mixed-citation><mixed-citation xml:lang="en">Mai W, Xu Y, Xu J, Zhao D, Ye L, Yu G, Wang Z, Lu Q, Lin J, Yang T, Gu C, Liu S, Zhong Y, Yang H. Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis. Front Pharmacol. 2020 Mar 3;11:185. DOI: 10.3389/fphar.2020.00185.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hosseini E., Ghasemzadeh M., Atashibarg M., Haghshenas M. ROS scavenger, N-acetyl-l-cysteine and NOX specific inhibitor, VAS2870 reduce platelets apoptosis while enhancing their viability during storage // Transfusion. – 2019. – Vol. 59, No.4. – P. 1333–1343. DOI: 10.1111/trf.15114.</mixed-citation><mixed-citation xml:lang="en">Haghshenas M. ROS scavenger, N-acetyl-l-cysteine and NOX specific inhibitor, VAS2870 reduce platelets apoptosis while enhancing their viability during storage. Transfusion. 2019 Apr; 59(4):1333–43. DOI: 10.1111/trf.15114.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Воронков А.В., Поздняков Д.И., Руковицина В.М., Вселова О.Ф., Олохова Е.А., Оганесян Э.Т. Антирадикальные и хелатирующие свойства производных хромон-3-альдегида // Экспериментальная и клиническая фармакология. – 2019. – Т. 82, № 12. – С. 32–35. DOI: 10.30906/0869-2092-2019-82-12-32-35.</mixed-citation><mixed-citation xml:lang="en">Pozdnyakov DI, Voronkov AV, Rukovitsyna VM. Chromon-3-aldehyde derivatives restore mitochondrial function in rat cerebral ischemia. Iran J Basic Med Sci. 2020 Sep;23(9):1172–83. DOI: 10.22038/ijbms.2020.46369.10710.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Yang C.S., Ho C.T., Zhang J., Wan X., Zhang K., Lim J. Antioxidants: Differing Meanings in Food Science and Health Science // J Agric Food Chem. – 2018. – Vol. 66, No.12. – P. 3063–3068. DOI: 10.1021/acs.jafc.7b05830.</mixed-citation><mixed-citation xml:lang="en">Yang CS, Ho CT, Zhang J, Wan X, Zhang K, Lim J. Antioxi-dants: Differing Meanings in Food Science and Health Science. J Agric Food Chem. 2018 Mar 28;66(12):3063–8. DOI: 10.1021/acs.jafc.7b05830.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mohsin N.Ua., Irfan M., Hassan S.U., Saleem U. Current Strategies in Development of New Chromone Derivatives with Diversified Pharmacological Activities: A Review // Pharm Chem J. – 2020. – Vol. 1. – P. 17. DOI: 10.1007/s11094-020-02187-x.</mixed-citation><mixed-citation xml:lang="en">Mohsin NUa, Irfan M, Hassan SU, Saleem U. Current Strategies in Development of New Chromone Derivatives with Diversified Pharmacological Activities: A Review. Pharm Chem J. 2020;1:17. DOI: 10.1007/s11094-020-02187-x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
